Gemcitabine-based combination treatment of pancreatic cancer

被引：44
|
作者：
Heinemann, V [1 ]
机构：
[1] Klinikum Grosshadern, Med Clin 3, D-81377 Munich, Germany
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30749
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 35
页数：11
相关论文
共 50 条
  • [41] Sensitization of Radiation or Gemcitabine-Based Chemoradiation Therapeutic Effect by Nimotuzumab in Pancreatic Cancer Cells
    Gao, Chunzi
    Wu, Xianzhen
    Yan, Ying
    Meng, Lingnan
    Shan, Dan
    Li, Ying
    Han, Bo
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (03) : 446 - 452
  • [42] Is skeletal muscle a predictor of toxicity in pancreatic cancer patients on gemcitabine-based chemotherapy regimens?
    Freckelton, J.
    Croagh, D.
    Holt, D. Q.
    Fox, A.
    Wong, R.
    Moore, G. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 58 - 58
  • [43] Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
    Heinemann, Volker
    Boeck, Stefan
    Hinke, Axel
    Labianca, Roberto
    Louvet, Christophe
    BMC CANCER, 2008, 8 (1)
  • [44] PROGNOSTIC IMPLICATION OF GEMCITABINE-BASED CHEMOTHERAPY AND INTRAOPERATIVE RADIATION THERAPY IN UNRESECTABLE PANCREATIC CANCER
    Fujii, T.
    Nagai, S.
    Kanda, M.
    Kodera, Y.
    Sahin, T. T.
    Sugimoto, H.
    Nomoto, S.
    Takeda, S.
    Nakao, A.
    Morita, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 263 - 263
  • [45] Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
    Volker Heinemann
    Stefan Boeck
    Axel Hinke
    Roberto Labianca
    Christophe Louvet
    BMC Cancer, 8
  • [46] A prospective randomized trial on two gemcitabine-based regimens of chemotherapy for unresectable pancreatic cancer
    Popiela, T
    Kulig, J
    Sierzega, M
    Legutko, J
    GASTROENTEROLOGY, 2005, 128 (04) : A109 - A109
  • [47] Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A systematic review and meta-analysis of randomized trials
    Ciliberto, Domenico
    Botta, Cirino
    Correale, Pierpaolo
    Mazzanti, Roberto
    Mantovani, Giovanni
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy
    Lautenschlaeger, S.
    Dumke, C.
    Exeli, L.
    Hauswald, H.
    Engenhart-Cabillic, R.
    Eberle, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (11) : 982 - 991
  • [49] Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy
    S. Lautenschlaeger
    C. Dumke
    L. Exeli
    H. Hauswald
    R. Engenhart-Cabillic
    F. Eberle
    Strahlentherapie und Onkologie, 2023, 199 : 982 - 991
  • [50] The pemetrexed/gemcitabine combination in pancreatic cancer
    Kindler, HL
    CANCER, 2002, 95 (04) : 928 - 932
12345